Structural requirements for TLR4-mediated LPS signalling: A biological role for LPS modifications

Microbes and Infection

Volumn 5, Issue 12, 2003, Pages 1057-1063

  Bäckhed, Fredrik ^a,d   Normark, Staffan ^a   Schweda, Elke K H ^b   Oscarson, Stefan ^c   Richter Dahlfors, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial cells; LPS; TLR4

Indexed keywords

INTERLEUKIN 8; LIPID A; LIPOPOLYSACCHARIDE; O ANTIGEN; TOLL LIKE RECEPTOR 4;

ACYLATION; ANTIGEN FUNCTION; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; CARBOHYDRATE ANALYSIS; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENTEROBACTERIACEAE; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; INHIBITION KINETICS; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; WILD TYPE;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 19244371803     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00207-7     Document Type: Article

References (39)

1. Joiner K.A. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42:1988;201-230.
2. Wyckoff T.J., Raetz C.R., Jackman J.E. Antibacterial and anti-inflammatory agents that target endotoxin. Trends Microbiol. 6:1998;154-159.
3. Karow M., Georgopoulos C. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J. Bacteriol. 174:1992;702-710.
4. Munford R.S., Hall C.L. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science. 234:1986;203-205.
5. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266:1991;19490-19498.
6. Christ W.J., Asano O., Robidoux A.L., Perez M., Wang Y., Dubuc G.R., Gavin W.E., Hawkins L.D., McGuinness P.D., Mullarkey M.A., et al. E5531, a pure endotoxin antagonist of high potency. Science. 268:1995;80-83.
7. Hedlund M., Wachtler C., Johansson E., Hang L., Somerville J.E., Darveau R.P., Svanborg C. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol. Microbiol. 33:1999;693-703.
8. Somerville J.E. Jr, Cassiano L., Bainbridge B., Cunningham M.D., Darveau R.P. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Invest. 97:1996;359-365.
9. Khan S.A., Everest P., Servos S., Foxwell N., Zahringer U., Brade H., Rietschel E.T., Dougan G., Charles I.G., Maskell D.J. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:1998;571-579.
10. Low K.B., Ittensohn M., Le T., Platt J., Sodi S., Amoss M., Ash O., Carmichael E., Chakraborty A., Fischer J., Lin S.L., Luo X., Miller S.I., Zheng L., King I., Pawelek J.M., Bermudes D. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nat. Biotechnol. 17:1999;37-41.
11. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., et al. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
12. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
13. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
14. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., Wright S.D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. M. 176:1992;1665-1671.
15. Wright S.D. CD14 and innate recognition of bacteria. J. Immunol. 155:1995;6-8.
16. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. M. 189:1999;1777-1782.
17. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
18. da Silva Correia J., Ulevitch R.J. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277:2002;1845-1854.
19. Jiang Q., Akashi S., Miyake K., Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. J. Immunol. 165:2000;3541-3544.
20. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
21. Kopp E.B., Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:1999;13-18.
22. Bäckhed F., Soderhall M., Ekman P., Normark S., Richter-Dahlfors A. Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol. 3:2001;153-158.
23. Schilling J.D., Mulvey M.A., Vincent C.D., Lorenz R.G., Hultgren S.J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166:2001;1148-1155.
24. Bäckhed F., Normark S., Richter-Dahlfors A. TLR4-dependent lipopolysaccharide signalling in epithelial cells is independent of extracellular protease activity. Cell Microbiol. 4:2002;297-303.
25. Bäckhed F., Meijer L., Normark S., Richter-Dahlfors A. TLR4-dependent recognition of lipopolysaccharide by epithelial cell requires sCD14. Cell Microbiol. 4:2002;493-503.
26. Schilling J.D., Martin S.M., Hunstad D.A., Patel K.P., Mulvey M.A., Justice S.S., Lorenz R.G., Hultgren S.J. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect. Immun. 71:2003;1470-1480.
27. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:2000;497-504.
28. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA. 97:2000;2163-2167.
29. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359.
30. Darveau R.P., Cunningham M.D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., Dietsch M., Page R.C., Aruffo A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 63:1995;1311-1317.
31. Bäckhed F., Rokbi B., Torstensson E., Zhao Y., Nilsson C., Seguin D., Normark S., Buchan A.M., Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187:2003;829-836.
32. Weintraub A., Zahringer U., Wollenweber H.W., Seydel U., Rietschel E.T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur. J. Biochem. 183:1989;425-431.
33. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:1991;80-128.
34. Muroi M., Tanamoto K. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-κB through human Toll-like receptor 4. Infect. Immun. 70:2002;6043-6047.
35. Kitchens R.L., Munford R.S. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:1995;9904-9910.
36. Heine H., Brade H., Kusumoto S., Kusama T., Rietschel E.T., Flad H.-D., Ulmer A.J. Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A. J. Endotoxin Res. 1:1994;14-20.
37. Kirikae T., Schade F.U., Zahringer U., Kirikae F., Brade H., Kusumoto S., Kusama T., Rietschel E.T. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. FEMS Immunol. Med. Microbiol. 8:1994;13-26.
38. Suda Y., Ogawa T., Kashihara W., Oikawa M., Shimoyama T., Hayashi T., Tamura T., Kusumoto S. Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide. J. Biochem. (Tokyo). 121:1997;1129-1133.
39. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22:2002;283-307.